Total buying$00 buys
QTTB
Q32 Bio Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 09/20 to 10/20.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$45.2k3 sells
Net open-market−$45.2kBuying minus selling
Active insiders3Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 14, 2026
Open-market transaction mix · 3 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 0 | 0 | 0 | $0 | $0 | $0 |
| Oct 2026 | 0 | 3 | 0 | $0 | $45.2k | -$45.2k |
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (3)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- MP-$26.8k
- KL-$10.8k
- VM-$7.6k
QTTB transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
QTTBQ32 Bio Inc. | Morrison Jodie PopeCEO | S · saleSEC filing ↗ | -$26.7kView disclosure → | |
QTTBQ32 Bio Inc. | Kalowski LeeCFO · PRES | S · saleSEC filing ↗ | -$10.8kView disclosure → | |
QTTBQ32 Bio Inc. | Violette Shelia M.CSO | S · saleSEC filing ↗ | -$7.62kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Recent filing activity
Most recent 3 transactions on this page · color = transaction codeFiling detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period3transactionstxns
- S · Open-market sells · dominant3 · 100%
Activity by reported role
A joint filing can contribute to multiple rolesChief executive officer1
Chief financial officer1
CSO1
PRES1
Reported Holdings After
Separated by insider, security, and ownership type
Kalowski LeeCommon Stock · Direct
137,170Oct 06, 2026
Violette Shelia M.Common Stock · Direct
126,854Oct 06, 2026
Morrison Jodie PopeCommon Stock · Direct
340,038Oct 06, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 20 → Oct 20
LessMore
Q32 Bio Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Q32 Bio Inc.?
Morrison Jodie Pope, Kalowski Lee, Violette Shelia M..
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Morrison Jodie Pope reported a sale on Oct 06, 2026 valued at $26.7k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $45,251.30. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.